```json
{
"content": [
{
"type": "paragraph",
"content": "The tumor ablation interventional radiology ecosystem spans upstream technology and component suppliers, midstream system manufacturers and integrators, and downstream healthcare providers. Value creation occurs through innovation in ablation technologies, integration of imaging systems, and access to clinical settings where minimally invasive tumor treatments are prioritized."
},
{
"type": "list",
"items": [
{ "text": "Raw material/component suppliers — provide ablation probes, generators, and other hardware components.", "level": 1 },
{ "text": "OEMs / manufacturers — produce single-use and reusable ablation devices with varying energy modalities.", "level": 1 },
{ "text": "Technology providers — develop imaging guidance and motion compensation software for precise tumor targeting.", "level": 1 },
{ "text": "System integrators — assemble ablation systems with compatible imaging and targeting technologies.", "level": 1 },
{ "text": "Distributors / channel partners — manage logistics and supply chain to connect manufacturers with healthcare facilities.", "level": 1 },
{ "text": "Service providers / after-sales — offer installation, training, maintenance, and repair services for ablation systems.", "level": 1 },
{ "text": "End users / buyers — include hospitals, ambulatory surgery centers, and cancer treatment centers utilizing ablation therapies.", "level": 1 }
]
},
{
"type": "paragraph",
"content": "Control points reside with regulators (approvals), technology providers (standards), and OEMs (product specifications). Dependency risks include component shortages, regulatory delays, and interoperability constraints with imaging systems. High switching costs for end users stem from specialized training and system integration, while partnerships between OEMs and imaging firms strengthen value chain alignment."
}
]
}
```
